The companys entry into obesity combines this antibody expertise with GLP-1 biology, however, its focus is testing whether muscle-preserving antibodies, including trevogrumab, a myostatin inhibitor, can be combined with semaglutide to address the lean-mass loss associated with GLP-1 monotherapy
Semaglutide Diarrhea Causes, Explained You can think of disruptions to your GI system like an intersection that desperately needs a traffic cop but doesnt have one
Lilly, Chasing Novo, Expects Second-Quarter FDA Decision on Obesity Pill
Key moves include: Geographic expansion : Lilly has out-licensed tirzepatide to partners in Asia (e.g., in China and India) to accelerate uptake outside the U.S./EU
Persistent fatigue should be reviewed with a physician so the plan can support energy, muscle, hydration, and metabolic health